Animal AgTech Innovation Summit’s Post

This week Renaud JACQUEMART, PhD, MBA is representing FABP Biotech at #AHNTI2024 in Boston. As we develop innovative anti-helminth #vaccines for livestock and companion animals, we are eager to #connect with potential partners and investors who share our vision for advancing animal healthcare. Please reach out to set up a meeting if you are interested in exploring collaboration opportunities or investment prospects with FABP Biotech. About Kisaco Research Animal Health, Nutrition, & Technology Summit: Animal Health, Nutrition and Technology Innovation Europe is the sector’s premier innovation summit, showcasing the most exciting emerging companies and connecting them with investors and strategic partners. Their mission is to engage all key participants in the value chain to address the full scope of how animal health impacts pet owners, veterinarians, and farmers today. Over the past 9 years, they have partnered with the industry's biggest companies and most exciting start-ups to facilitate acquisitions, partnerships and investments. #animalhealth #vaccinedevelopment #animalvaccines #vaccineplatform #globalhealth #biotechinnovation #biotech #startups #Collaboration #networking #innovation #vaccineinnovation #heartworm #liverfluke #AHNTI

Historically, companion animal health originators enjoyed strong durability and high brand loyalty, without the looming threat of a patent cliff. But recently, the industry has seen #generics players entering the market swiftly after patent expiry. Now more than ever, it’s crucial to strengthen your competitive edge and focus on you unique selling proposition. Ready to stay ahead? #AnimalHealth #Generics #Patent #Consulting #Strategy

Sequent Scientific and Viyash Life Sciences Merge: A Game-Changing ₹8,000-Crore Deal in the Animal Health Sector! Sequent Scientific and Viyash Life Sciences have joined forces in a monumental ₹8,000 crore merger, creating a powerhouse in the animal health industry. This merger is set to redefine the landscape, enabling advanced R&D, wider market reach, and innovative health solutions for livestock and pets. With both companies combining their strengths, this deal promises to drive growth, enhance product portfolios, and open up new avenues for addressing global animal healthcare needs. https://lnkd.in/eQ_hkc2r #SequentScientific #ViyashLifeSciences #AnimalHealth #PharmaMerger #HealthcareInnovation #VeterinaryCare #AnimalWellness #Pharmaceuticals #GlobalHealth #IndustryTransformation #Youtubeshorts #Shorts #Facebook #Linkedln What do you think this merger means for the future of animal healthcare? Share your thoughts in the comments, and follow us for more updates on the latest industry moves!

Sequent Scientific and Viyash Life Sciences Merge: A Game-Changing ₹8,000-Crore Deal in the Animal Health Sector! Sequent Scientific and Viyash Life Sciences have joined forces in a monumental ₹8,000 crore merger, creating a powerhouse in the animal health industry. This merger is set to redefine the landscape, enabling advanced R&D, wider market reach, and innovative health solutions for livestock and pets. With both companies combining their strengths, this deal promises to drive growth, enhance product portfolios, and open up new avenues for addressing global animal healthcare needs. https://lnkd.in/eQ_hkc2r #SequentScientific #ViyashLifeSciences #AnimalHealth #PharmaMerger #HealthcareInnovation #VeterinaryCare #AnimalWellness #Pharmaceuticals #GlobalHealth #IndustryTransformation #Youtubeshorts #Shorts #Facebook #Linkedln What do you think this merger means for the future of animal healthcare? Share your thoughts in the comments, and follow us for more updates on the latest industry moves!

Controlled-release microspheres can offer a robust solution to tough challenges in drug delivery in pets and livestock, but navigating the complexities of their development and manufacture is no easy task. Download our insight-packed microspheres fact sheet and discover: ‣ What microspheres are ‣ All about Argenta’s licensable microspheres technology, including its key specifications ‣ How our microspheres can help you overcome some of the toughest drug delivery challenges — from poor bioavailability to uncontrolled API release ‣ The range of APIs, administration routes, species, and indications for which our microspheres are suitable ‣ How we can help speed the path from 'molecule to market' for microspheres-based therapies https://hubs.li/Q02hTf3Q0 #CRO #CDMO #VeterinaryInnovation #DrugDeliveryTechnology #AnimalHealth

📢 Last call for entries --> Animal Health Technology & Innovation Conference Start-up Showcase deadline is this Friday, March 29th. The 2024 Kisaco Research conference takes place 6/11-13 in Boston. [ join me! ] What I can tell you is → I went last year and the mix of investors, industry experts, vendors and established brands was fairly well balanced. I believe they are in the 6th year of hosting AHNTI USA.   Proof is often in the #'s: 🐮 CattleEye → $2.5 million directly off the investors they met at ANHTI 🧪 Rejuvenate Bio → $10 million Series A round via a lead investor met at ANHTI 💊 PetMedix → $11 million investment + key strategic partners tied to ANHTI The application process is not to challenging. 1/2 dozen open form questions & some capes/creds that you should already have. Interested, LMK. Want to poke around, visit: https://lnkd.in/dYH4YV8x CC Harrison Sharp, Stephen Swarray, Rhian Collinson, Femi Adetoro, Amy Beck #Petcare #AnimalHealth #Innovation #Startup #Showcase #AlwaysLearning

Animal Growth Promoters Market Size to Hit USD 21.4 Billion by 2026 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬: https://lnkd.in/dHc_2w_W The size of animal growth promoters and performance enhancers market industry is projected to grow from $16.2 billion in 2021 and to reach $21.4 billion by 2026, at a Compound Annual Growth Rate (CAGR) of 5.7% during the forecast period. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Cargill Elanco (Shanghai) Animal Health Co Ltd Boehringer Ingelheim Merck & Co., Inc. ADM Alltech Evonik Vetoquinol Global BupoAnimalHealth Novus International, Inc. Associated British Foods plc Phibro Animal Health Kemin Industries Zoetis Nutreco Novozymes Land O'Lakes, Inc. Chr. Hansen Biomin Holding GmbH Lallemand

The International Animal Health Journal has featured Syngene in an article titled “The Importance of Strategic Investments and Technological Advancements.” In the article, Alex Del Priore, SVP - Manufacturing Services at Syngene emphasizes the importance of strong CDMO partnerships built on trust, quality, compliance, and effective communication. He also discusses the agility and flexibility needed to adapt to market demands and regulations. The piece highlights Syngene's decade-long partnership with Zoetis, showcasing the Company's infrastructure, technical expertise, and scalable manufacturing facilities as key differentiators. Read the full article 👉 link in the comments section. 🔗

Check out my article!

Great and insightful discussion on AMR.